Complete Resolution of Disease After Peptide Receptor Radionuclide Therapy in a Patient of Metastatic Insulinoma
dc.contributor.author | Verma, P. | |
dc.contributor.author | Malhotra, G. | |
dc.contributor.author | Dodamani, M. H. | |
dc.contributor.author | Lila, A. R. | |
dc.contributor.author | Asopa, R. V. | |
dc.contributor.author | Bandgar, T. R. | |
dc.date.accessioned | 2024-08-29T09:11:17Z | |
dc.date.available | 2024-08-29T09:11:17Z | |
dc.date.issued | 2022 | |
dc.description.division | RMC | en |
dc.format.extent | 4019 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.source | Clinical Nuclear Medicine, 2022. Vol. 47: pp. 77-78 | en |
dc.identifier.uri | http://hdl.handle.net/123456789/27252 | |
dc.language.iso | en | en |
dc.subject | insulinoma | en |
dc.subject | liver metastases | en |
dc.subject | peptide receptor radionuclide therapy | en |
dc.subject | 177Lu-DOTATATE | en |
dc.subject | 68Ga-DOTATATE PET/CT | en |
dc.title | Complete Resolution of Disease After Peptide Receptor Radionuclide Therapy in a Patient of Metastatic Insulinoma | en |
dc.type | Article | en |